Thomas A. MCCOURT - 22 Dec 2021 Form 4 Insider Report for IRONWOOD PHARMACEUTICALS INC (IRWD)

Role
Chief Executive Officer, Director
Signature
/s/ Brian Tessler, Attorney-in-Fact
Issuer symbol
IRWD
Transactions as of
22 Dec 2021
Net transactions value
-$528,591
Form type
4
Filing time
23 Dec 2021, 15:18:28 UTC
Previous filing
24 Nov 2021
Next filing
21 Jan 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IRWD Class A Common Stock Sale $528,591 -46,327 -7.5% $11.41 574,454 22 Dec 2021 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
F2 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.28 to $11.55, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
F3 The reporting person acquired 2,236 shares of Class A common stock under the issuer's employee stock purchase plan on June 30, 2021.

Remarks:

Exhibit 24: Power of Attorney